Showing results (1-10 of 9) with videos related to
Sort By:
Pageof 1
CNS Drugs|July 10, 2025
Investigational Gene Therapies for Parkinson's DiseaseNicolas Phielipp, Claire HenchcliffeJournal of Robotic Surgery|September 15, 2019
Two-year clinical outcomes associated with robotic-assisted subthalamic lead implantation in patients with Parkinson's diseaseMichelle Paff, Alice S Wang, Nicolas Phielipp, et al.Movement Disorders Clinical Practice|December 18, 2024
Diagnostic Utility of Clinical Neurophysiology in Jerky Movement Disorders: A Review from the MDS Clinical Neurophysiology Study GroupAnna Latorre, Christos Ganos, Masashi Hamada, et al.Parkinsonism & Related Disorders|October 7, 2015
What is a clinically important change in the Unified Dyskinesia Rating Scale in Parkinson's disease?Tiago A Mestre, Isabelle Beaulieu-Boire, Camila C Aquino, et al.Journal of Neurology, Neurosurgery, and Psychiatry|August 31, 2012
Clinical features of dopamine agonist withdrawal syndrome in a movement disorders clinicMargarita Pondal, Connie Marras, Janis Miyasaki, et al.Brain : a Journal of Neurology|September 28, 2016
A case cluster of variant Creutzfeldt-Jakob disease linked to the Kingdom of Saudi ArabiaMichael B Coulthart, Michael D Geschwind, Shireen Qureshi, et al.Annals of Neurology|January 26, 2018
Pallidal deep brain stimulation modulates cortical excitability and plasticityZhen Ni, Sang Jin Kim, Nicolas Phielipp, et al.JAMA Neurology|November 23, 2020
Effect of Ezogabine on Cortical and Spinal Motor Neuron Excitability in Amyotrophic Lateral Sclerosis: A Randomized Clinical TrialBrian J Wainger, Eric A Macklin, Steve Vucic, et al.Movement Disorders : Official Journal of the Movement Disorder Society|September 6, 2025
ENLITE PD: A Randomized Clinical Trial of Light Therapy for Impaired Sleep in Parkinson's DiseaseAleksandar Videnovic, Christopher S Coffey, Elizabeth B Klerman, et al.Pageof 1